Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Lin T et al. | 2014 | intact cell/cell culture, MDA-MB-468 cell line and T47D cell line (human breast carcinoma cells) | static magnetic field, DC | 3 mT |
Kimura T et al. | 2008 | invertebrate, <i>Caenorhabditis elegans</i> (nematode; different strains) | static magnetic field, DC, co-exposure | 2–5 T |
Tavasoli Z et al. | 2009 | intact cell/cell culture, bone marrow stem cells (rat) | static magnetic field, DC, co-exposure | 15 mT |
Chignell CF et al. | 1995 | intact cell/cell culture, erythrocytes | static magnetic field, DC, co-exposure | 0.335 T |
Mariani F et al. | 2001 | intact cell/cell culture, monocyte-derived macrophages | static magnetic field, DC, co-exposure | 232–670 mT |
Ghibelli L et al. | 2006 | intact cell/cell culture, Jurkat cells (human lymphoblastoid T cells) and U937 (human leukemic monocyte cell line) | static magnetic field, MRI, therapeutic/medical device | 6 mT–1 T |
Kamalipooya S et al. | 2017 | intact cell/cell culture, HeLa (human cervical carcinoma cell line) and Hu02 cells (mesenchymal skin fibroblasts) | static magnetic field, also other exposures without EMF, co-exposure | - |
Satari M et al. | 2021 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line) and Huo2 cells (skin fibroblast cells) | static magnetic field, also other exposures without EMF, co-exposure | - |
Yudhistiara B et al. | 2019 | intact cell/cell culture, TK6 cells (lymphoblastoma cells) | static magnetic field, also other exposures without EMF, co-exposure | - |
Kimsa-Dudek M et al. | 2022 | intact cell/cell culture, C32 cells (human melanoma cell line) | static magnetic field, also other exposures without EMF, co-exposure | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.